CRIS Current Research Information System

GARAJOVA, INGRID
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 3.430
NA - Nord America 3.396
EU - Europa 2.221
AF - Africa 169
Continente sconosciuto - Info sul continente non disponibili 158
SA - Sud America 138
OC - Oceania 9
Totale 9.521
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.336
VN - Vietnam 1.020
SG - Singapore 913
CN - Cina 760
IT - Italia 558
GB - Regno Unito 476
DE - Germania 248
SE - Svezia 236
HK - Hong Kong 218
IN - India 130
FR - Francia 123
KR - Corea 106
RU - Federazione Russa 105
BR - Brasile 92
BD - Bangladesh 84
FI - Finlandia 75
IE - Irlanda 75
CH - Svizzera 73
NL - Olanda 72
JP - Giappone 64
ZA - Sudafrica 48
UA - Ucraina 38
CI - Costa d'Avorio 36
EE - Estonia 34
TG - Togo 34
CA - Canada 31
SC - Seychelles 26
BE - Belgio 19
BG - Bulgaria 19
PH - Filippine 19
JO - Giordania 18
ID - Indonesia 14
MX - Messico 14
PL - Polonia 14
TR - Turchia 14
TH - Thailandia 13
AR - Argentina 12
AT - Austria 12
EC - Ecuador 11
GR - Grecia 11
NG - Nigeria 11
IQ - Iraq 9
PK - Pakistan 9
TW - Taiwan 9
SA - Arabia Saudita 8
ES - Italia 7
VE - Venezuela 7
AU - Australia 6
IR - Iran 6
CL - Cile 5
CO - Colombia 5
PT - Portogallo 5
RO - Romania 5
JM - Giamaica 4
NI - Nicaragua 4
BH - Bahrain 3
CZ - Repubblica Ceca 3
EG - Egitto 3
HR - Croazia 3
LT - Lituania 3
PE - Perù 3
PS - Palestinian Territory 3
DZ - Algeria 2
KE - Kenya 2
LB - Libano 2
MA - Marocco 2
MN - Mongolia 2
MY - Malesia 2
PY - Paraguay 2
SK - Slovacchia (Repubblica Slovacca) 2
UZ - Uzbekistan 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
BO - Bolivia 1
BW - Botswana 1
CR - Costa Rica 1
DJ - Gibuti 1
ET - Etiopia 1
FJ - Figi 1
GP - Guadalupe 1
HN - Honduras 1
HT - Haiti 1
HU - Ungheria 1
LU - Lussemburgo 1
MD - Moldavia 1
MM - Myanmar 1
NZ - Nuova Zelanda 1
PR - Porto Rico 1
RS - Serbia 1
SN - Senegal 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
TV - Tuvalu 1
VC - Saint Vincent e Grenadine 1
Totale 9.363
Salva come PNG Salva come JPEG
Città #
Singapore 645
Southend 410
Ashburn 323
Fairfield 283
Ho Chi Minh City 250
Hanoi 236
Chandler 223
Hong Kong 200
San Jose 189
Hefei 185
Santa Clara 157
Dallas 144
Houston 137
Wilmington 137
Woodbridge 125
Seattle 120
Ann Arbor 118
Dong Ket 98
Princeton 97
Cambridge 96
Seoul 93
Boardman 89
Bologna 89
Beijing 85
Dublin 75
Helsinki 69
Bern 66
Council Bluffs 64
Los Angeles 54
Tokyo 53
Lauterbourg 50
Nanjing 48
Rome 47
New York 45
Westminster 42
Berlin 41
Padova 38
Abidjan 36
Da Nang 35
Lomé 34
Milan 30
Frankfurt am Main 29
Haiphong 29
Buffalo 26
Medford 21
Turin 21
Bengaluru 19
Saint Petersburg 19
Sofia 19
Amman 18
Changsha 17
Shenyang 17
Guangzhou 16
Redondo Beach 16
Brussels 15
San Diego 14
Toronto 14
Jinan 13
London 13
Orem 13
Phoenix 13
Ravenna 13
Tianjin 13
Hebei 12
Nuremberg 12
Rimini 12
São Paulo 12
Dearborn 11
Phủ Lý 11
Atlanta 10
Jacksonville 10
Shanghai 10
Warsaw 10
Amsterdam 9
Nha Trang 9
Quận Ba 9
Tongling 9
Vũng Tàu 9
Bến Tre 8
Falls Church 8
Florence 8
Hangzhou 8
Hải Dương 8
Olalla 8
Quận Bình Thạnh 8
Zhengzhou 8
Abeokuta 7
Bắc Giang 7
Can Tho 7
Chicago 7
Denver 7
Munich 7
Mülheim 7
Norwalk 7
Parma 7
Poplar 7
Torino 7
Wuhan 7
Xi'an 7
Bangkok 6
Totale 6.060
Salva come PNG Salva come JPEG
Nome #
Follow-up del cancro del pancreas esocrino 470
D32Left versus right side primary tumor: the correlation with clinical outcome of patients with resected stage II and III colorectal cancer 311
SUSTAINED COMPLETE RESPONSE OF ADVANCED HEPATOCELLULAR CARCINOMA WITH METRONOMIC CAPECITABINE: A REPORT OF THREE CASES 305
Bone Metastases from Intrahepatic Cholangiocarcinoma Confer Worse Prognosis 284
Synergic activity of FGFR2 and MEK inhibitors in the treatment of FGFR2-amplified cancers of unknown primary 273
[Possibilities of resistance prediction to neoadjuvant concomitant chemoradiotherapy in the treatment algorithm of patients with rectal carcinoma] 267
Brain Metastases from Biliary Tract Cancer: A Monocentric Retrospective Analysis of 450 Patients 253
Membrane human equilibrative nucleoside transporter 1 is associated with a high proliferation rate and worse survival in resected intrahepatic cholangiocarcinoma patients not receiving adjuvant treatments 248
FOLFIRINOX and translational studies: Towards personalized therapy in pancreatic cancer 230
Membrane localization of human equilibrative nucleoside transporter 1 in tumor cells may predict response to adjuvant gemcitabine in resected cholangiocarcinoma patients 229
Real-World Impact of Olaparib Exposure in Advanced Pancreatic Cancer Patients Harboring Germline BRCA1-2 Pathogenic Variants 216
Asbestos: a putative risk factor for intrahepatic cholangiocarcinoma 216
Second surgery or chemotherapy for relapse after radical resection of colorectal cancer metastases. 213
Metronomic capecitabine vs. best supportive care in Child-Pugh B hepatocellular carcinoma: A proof of concept 211
Heterotopic auxiliary segment 2–3 liver transplantation with delayed total hepatectomy: New strategies for nonresectable colorectal liver metastases 207
219 MiR-21 expression correlates with prognosis in extrahepatic radically resected cholangiocarcinomas treated with gemcitabine-based adjuvant chemotherapy 206
Antiapoptotic genes are overexpressed in the group of patients with locally advanced rectal adenocarcinomas who do not respond to neoadjuvant chemoradiotherapy 196
In Reply 196
Suboptimal outcomes of sorafenib as a second-line treatment after atezolizumab-bevacizumab for unresectable hepatocellular carcinoma 195
Epigenetic and epitranscriptomic changes in colorectal cancer: diagnostic, prognostic, and treatment implications 192
Should patients on levothyroxine therapy be screened for pancreatic cancer? 186
Second-line chemotherapy in patients with biliary tract cancer. 182
Postsorafenib systemic treatments for hepatocellular carcinoma: Questions and opportunities after the regorafenib trial 180
[Gene expression profiling in prediction of tumor response to neoadjuvant concomitant chemoradiotherapy in patients with locally advanced rectal carcinoma: pilot study] 177
Second-line therapy in pancreatic ductal adenocarcinoma (PDAC) patients with germline BRCA1-2 pathogenic variants (gBRCA1-2pv) 176
Circulating microRNAs as dynamic biomarkers of response to treatment with FOLFIRINOX combination therapy in advanced pancreatic ductal adenocarcinoma 172
EXPOSURE TO ASBESTOS: A PUTATIVE UNKNOWN RISK FACTOR FOR INTRAHEPATIC CHOLANGIOCARCINOMA 168
MicroRNA profiling of primary pulmonary enteric adenocarcinoma in members from the same family reveals some similarities to pancreatic adenocarcinoma-a step towards personalized therapy 166
Chemotherapy toxicity and activity in patients with pancreatic ductal adenocarcinoma and germline BRCA1-2 pathogenic variants (gBRCA1-2pv): a multicenter survey 159
The follow-up issues: from the necessity to the opportunity 156
c-Met as a Target for Personalized Therapy 152
Port-a-Cath-related complications in 252 patients with solid tissue tumours and the first report of heparin-induced delayed hypersensitivity after Port-a-Cath heparinisation. 151
Second-line chemotherapy in biliary tract cancer patients. 151
Feasibility of triplets (5-FU, oxaliplatin and irinotecan based) in front and subsequent lines of metastatic colorectal cancer patients. 145
Circulating micrornas as dynamic biomarkers of disease progression during folfirinox therapy in unresectable pancreatic ductal adenocarcinoma (pdac) 140
D43Capecitabine and Regorafenib-related increased mean corpuscular volume of red blood cell may be a predictive marker of treatment response and survival in patients with metastatic colorectal cancer 138
380 POSTER Association of miR21, miR31, miR143, miR145 and let-7a-1 levels with histopathologic features of colorectal cancer 133
Altered expression of heat shock protein 110 (HSP110), hypoxia up- regulated 1 (HYOU1) and translationally controled tumor protein (TCTP) during colorectal cancer progression 131
Significant overexpression of Hsp110 gene during colorectal cancer progression 128
Oxaliplatin in pre-treated patients: Maybe not the match point? 128
Neoadjuvant treatment in rectal cancer: actual status. 124
Prognostic significance of tumor-infiltrating cytotoxic T-cells in colorectal cancer 119
The role of microRNAs in resistance to current pancreatic cancer treatment: Translational studies and basic protocols for extraction and PCR analysis 118
Molecular Mechanisms Underlying the Role of MicroRNAs in the Chemoresistance of Pancreatic Cancer 118
Occupational exposure to asbestos: a putative unknown risk factor for intrahepatic cholangiocarcinoma. 113
D44The overall survival of patients affected by metastatic colorectal cancer before and after “monoclonal antibodies era”: a monocentric retrospective study 112
L27MiR-21 expression as prognostic biomarker in extrahepatic but not intrahepatic radically resected cholangiocarcinomas 108
MicroRNA profiling of primary pulmonary enteric adenocarcinoma shows similarity with lung cancer and pancreatic cancer 108
Pattern of progression of intrahepatic cholangiocarcinoma: Implications for second-line clinical trials 108
Targeted therapies for gallbladder cancer: an overview of agents in preclinical and clinical development 104
1517P Isolated LUng Metastases in pancreatic AdenoCArcinoma patients in a multicenter Italian cohort: The LU.M.A.CA study 84
Synchronous and metachronous colorectal liver metastases: Impact of primary tumor location on patterns of recurrence and survival after hepatic resection 72
Durvalumab in Advanced Biliary Tract Cancer: Real‐World Data From a Large Cohort of Patients Across Multiple International Centers 70
A multicenter study of skin toxicity management in patients with left-sided, RAS/BRAF wild-type metastatic colorectal cancer treated with first-line anti-EGFR-based doublet regimen: is there room for improvement? 67
Statins and clinical outcomes in patients with advanced hepatocellular carcinoma treated with Atezolizumab plus Bevacizumab 59
Totale 9.521
Salva come PNG Salva come JPEG
Categoria #
all - tutte 23.428
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 23.428
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022725 0 36 35 46 84 46 25 50 45 32 163 163
2022/20231.037 114 169 76 101 68 66 24 83 140 38 66 92
2023/2024269 39 40 9 32 11 51 9 17 11 14 22 14
2024/20251.419 54 215 118 73 215 55 107 79 44 81 108 270
2025/20263.672 357 439 380 217 301 176 489 133 657 228 138 157
2026/2027162 76 86 0 0 0 0 0 0 0 0 0 0
Totale 9.521